These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18444492)

  • 1. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.
    Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E
    Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind study of intranasal ipratropium bromide in nonallergic perennial rhinitis.
    Druce HM; Spector SL; Fireman P; Kaiser H; Meltzer EO; Boggs P; Wood CC; Paluch EP
    Ann Allergy; 1992 Jul; 69(1):53-60. PubMed ID: 1385682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis.
    Ozcan C; Vayisoglu Y; Doğu O; Görür K
    Am J Otolaryngol; 2006; 27(5):314-8. PubMed ID: 16935174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial.
    Unal M; Sevim S; Doğu O; Vayisoğlu Y; Kanik A
    Acta Otolaryngol; 2003 Dec; 123(9):1060-3. PubMed ID: 14710908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.
    Eccles R; Martensson K; Chen SC
    Curr Med Res Opin; 2010 Apr; 26(4):889-99. PubMed ID: 20151787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal ipratropium in the treatment of vasomotor rhinitis.
    Jokinen K; Sipilä P
    Rhinology; 1983 Dec; 21(4):341-5. PubMed ID: 6229864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal ipratropium: inhibition of methacholine induced hypersecretion.
    Borum P
    Rhinology; 1978 Dec; 16(4):225-33. PubMed ID: 154164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal disorders and anticholinergic therapy.
    Borum P
    Postgrad Med J; 1987; 63 Suppl 1():61-8. PubMed ID: 2962076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy.
    Yang TY; Jung YG; Kim YH; Jang TY
    Otolaryngol Head Neck Surg; 2008 Sep; 139(3):367-71. PubMed ID: 18722214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S; Nielsen K; Bisgaard H; Mygind N
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ipratropium bromide nasal spray in non-allergic rhinitis: efficacy, nasal cytological response and patient evaluation on quality of life.
    Georgitis JW; Banov C; Boggs PB; Dockhorn R; Grossman J; Tinkelman D; Roszko P; Wood C
    Clin Exp Allergy; 1994 Nov; 24(11):1049-55. PubMed ID: 7874603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the effect of ipratropium bromide as a pressurized aerosol and as an aqueous pump spray on methacholine-induced rhinorrhoea.
    Borum S; Becker B; Mygind N; Borum P
    Rhinology; 1996 Dec; 34(4):198-200. PubMed ID: 9050095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis.
    Cordray S; Harjo JB; Miner L
    Ear Nose Throat J; 2005 Jul; 84(7):426-30. PubMed ID: 16813032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin therapy in the ovalbumin-sensitized rat.
    Wen WD; Yuan F; Wang JL; Hou YP
    Neuroimmunomodulation; 2007; 14(2):78-83. PubMed ID: 17713354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal ipratropium: literature abstracts and comments.
    Mygind N; Borum P
    Rhinol Suppl; 1989; 9():37-44. PubMed ID: 2534054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies for botulinum toxin type A on allergic rhinitis in the rat.
    Wen WD; Yuan F; Hou YP; Song YF
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Feb; 39(2):97-101. PubMed ID: 15195592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
    Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
    Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis.
    Rohrbach S; Junghans K; Köhler S; Laskawi R
    Head Face Med; 2009 Oct; 5():18. PubMed ID: 19835591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A; Barnes M; Comiskey C
    Clin Rehabil; 2008 Jun; 22(6):513-9. PubMed ID: 18511531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dexpanthenol nasal spray as an effective therapeutic principle for treatment of rhinitis sicca anterior].
    Kehrl W; Sonnemann U
    Laryngorhinootologie; 1998 Sep; 77(9):506-12. PubMed ID: 9795928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.